Vista Pharmaceuticals Limited
BSE: VISTAPH
Prev Close
10.66
Open Price
10.84
Volume
2,626
Today Low / High
10.26 / 10.84
52 WK Low / High
9.1 / 13.09
Range
10 - 11
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 10.33, reflecting a change of -0.33 (-3.09568%). The expected target range on the BSE is 10 - 11. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Vista Pharmaceuticals Limited Graph
Vista Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Vista Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 10.33, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 10.33 | 10.43 | 9.39 - 11.48 |
| 10.54 | 8.43 - 12.64 | ||
| 10.64 | 7.45 - 13.83 | ||
| Bearish Scenario | 10.33 | 10.23 | 9.20 - 11.25 |
| 10.12 | 8.10 - 12.15 | ||
| 10.02 | 7.01 - 13.03 |
Overview of Vista Pharmaceuticals Limited
ISIN
INE427C01021
Industry
Medical - Pharmaceuticals
Vol.Avg
9,210
Market Cap
649,372,545
Last Dividend
0
Official Website
IPO Date
2002-01-11
DCF Diff
17.47
DCF
-4
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 10.07 Cr | 11.09 Cr | -1.01 Cr | -0.1006 | 0.00 Cr | 0.00 Cr | -4.77 Cr | -4.65 Cr | -0.76 | -3.59 Cr | -0.4614 |
| 2024-03-31 | 10.29 Cr | 12.22 Cr | -1.93 Cr | -0.1878 | 0.00 Cr | 1.90 Cr | -3.90 Cr | -4.51 Cr | -1.03 | -3.22 Cr | -0.4386 |
| 2023-03-31 | 1.00 Cr | 3.19 Cr | -2.19 Cr | -2.1824 | 0.00 Cr | 0.19 Cr | -4.63 Cr | -5.66 Cr | -1.54 | -4.05 Cr | -5.6411 |
| 2022-03-31 | 0.39 Cr | 0.61 Cr | -0.22 Cr | -0.5492 | 0.00 Cr | 0.10 Cr | -1.83 Cr | -0.89 Cr | -0.24 | -1.10 Cr | -2.2519 |
| 2021-03-31 | 1.27 Cr | 0.77 Cr | 0.49 Cr | 0.3908 | 0.00 Cr | 0.09 Cr | -2.46 Cr | -2.01 Cr | -0.58 | -1.53 Cr | -1.5861 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.73 Cr | 60.29 Cr | 14.87 Cr | 45.4225 Cr | 7.40 Cr | 6.67 Cr | 8.22 Cr | 19.29 Cr | 0.00 Cr | 0.00 Cr | 10.33 Cr | 12.3658 Cr |
| 2024-03-31 | 0.09 Cr | 57.98 Cr | 17.52 Cr | 40.4623 Cr | 7.96 Cr | 7.87 Cr | 6.79 Cr | 19.58 Cr | 0.00 Cr | 0.00 Cr | 0.02 Cr | 14.4923 Cr |
| 2023-03-31 | 0.14 Cr | 56.03 Cr | 19.32 Cr | 36.7077 Cr | 9.96 Cr | 9.82 Cr | 7.68 Cr | 19.51 Cr | -0.39 Cr | 0.00 Cr | 0.02 Cr | 14.0823 Cr |
| 2022-03-31 | 0.01 Cr | 55.59 Cr | 20.14 Cr | 35.4529 Cr | 12.55 Cr | 12.54 Cr | 9.33 Cr | 18.86 Cr | 0.80 Cr | 0.00 Cr | 0.03 Cr | 12.6393 Cr |
| 2021-03-31 | 0.08 Cr | 50.85 Cr | 18.01 Cr | 32.8460 Cr | 10.71 Cr | 10.63 Cr | 9.68 Cr | 19.46 Cr | 0.50 Cr | 0.00 Cr | 0.04 Cr | 9.2459 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -7.9486 Cr | -0.4400 Cr | 9.0275 Cr | -8.3886 Cr | 0.0000 Cr | 0.7333 Cr | -0.4400 Cr | -4.6487 Cr | -0.5603 Cr | 0.0000 Cr | -1.4340 Cr |
| 2024-03-31 | -4.9140 Cr | -0.7899 Cr | 5.5944 Cr | -5.7039 Cr | -0.1096 Cr | 0.0944 Cr | -0.7899 Cr | -4.5120 Cr | -1.4496 Cr | 0.0000 Cr | 0.8906 Cr |
| 2023-03-31 | -1.7114 Cr | -1.2703 Cr | 3.1138 Cr | -2.9817 Cr | 0.1321 Cr | 0.2040 Cr | -1.2703 Cr | -5.8763 Cr | -2.2465 Cr | 0.0000 Cr | 1.6508 Cr |
| 2022-03-31 | -0.9930 Cr | -0.0143 Cr | 0.9393 Cr | -1.0073 Cr | -0.0681 Cr | 0.0719 Cr | -0.0143 Cr | -2.6176 Cr | 0.6744 Cr | 0.0000 Cr | 0.3540 Cr |
| 2021-03-31 | -6.7466 Cr | -0.2990 Cr | 6.9605 Cr | -7.0456 Cr | -0.0852 Cr | 0.1400 Cr | -0.2990 Cr | -3.6878 Cr | -0.4906 Cr | 0.0000 Cr | 0.0001 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 3.23 Cr | 3.44 Cr | -0.21 Cr | -0.0648 | -1.10 Cr | -1.50 Cr | -0.24 | -0.67 Cr | -0.4631 |
| 2024-12-31 | 2.56 Cr | 2.50 Cr | 0.06 Cr | 0.0233 | -1.70 Cr | -1.32 Cr | -0.21 | -1.39 Cr | -0.5175 |
| 2024-09-30 | 2.49 Cr | 1.55 Cr | 0.94 Cr | 0.3773 | -1.01 Cr | -0.97 Cr | -0.16 | -0.82 Cr | -0.3903 |
| 2024-06-30 | 1.80 Cr | 1.60 Cr | 0.19 Cr | 0.1071 | -0.26 Cr | -0.86 Cr | -0.15 | -0.71 Cr | -0.4774 |
| 2024-03-31 | 3.13 Cr | 2.14 Cr | 0.99 Cr | 0.3157 | 0.10 Cr | 0.09 Cr | 0.02 | 0.36 Cr | 0.0290 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.73 Cr | 0.00 Cr | 0.73 Cr | 3.39 Cr | 8.22 Cr | 14.76 Cr | 19.29 Cr | 60.29 Cr | 14.87 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 2.64 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -48.23 Cr |
| 2024-09-30 | 2.64 Cr | 0.00 Cr | 2.64 Cr | 0.00 Cr | 9.83 Cr | 28.57 Cr | 19.47 Cr | 63.64 Cr | 15.41 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.09 Cr | 0.00 Cr | 0.00 Cr | 0.09 Cr | 0.00 Cr | 0.00 Cr | -40.46 Cr |
| 2024-03-31 | 0.09 Cr | 0.00 Cr | 0.09 Cr | 14.28 Cr | 6.79 Cr | 23.40 Cr | 19.58 Cr | 57.98 Cr | 17.52 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -1.32 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -0.97 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -0.86 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 0.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | -1.63 Cr | 0.37 Cr | 0.00 Cr | 0.00 Cr | 0.37 Cr | 0.61 Cr | 0.24 Cr | 0.00 Cr | 0.37 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2016-05-26 | May 26, 16 | 83:50 |
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹821.25 | ₹98,339,283,675.00 | ₹72,992.00 |
Key Executives
Gender: male
Year Born:
Gender: Not Specified
Year Born: 1950
Gender: male
Year Born:
Gender: male
Year Born:
Gender: female
Year Born:
FAQs about Vista Pharmaceuticals Limited
The CEO is Dhananjaya Alli.
The current price is ₹10.55.
The range is ₹9.1-13.09.
The market capitalization is ₹64.94 crores.
The P/E ratio is -13.58.
The company operates in the Healthcare sector.
Overview of Vista Pharmaceuticals Limited (ISIN: INE427C01021) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹64.94 crores and an average daily volume of 9,210 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.